João Pedro Tôrres Guimarães

João Pedro Tôrres Guimarães

Auto-generated profile, based on publicly available information

João Pedro Tôrres Guimarães

Laboratory of Nutrigenomics, Inflammation and Obesity Research, Department of Nutritional Sciences, Texas Tech University (TTU), Lubbock, TX 79409-1270, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
FMFlávia Sardela de Miranda
Flávia Sardela de Miranda
JGJoão Pedro Tôrres Guimarães
João Pedro Tôrres Guimarães
KMKalhara R. Menikdiwela
Kalhara R. Menikdiwela
BMBrennan Mabry
Brennan Mabry
Rabin DhakalRabin Dhakal
Rabin Dhakal
Naima Moustaid-MoussaNaima Moustaid-Moussa
Naima Moustaid-Moussa

1 January 2021 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
LQLuiz A. D. Queiroz
Luiz A. D. Queiroz
JAJosiane B. Assis
Josiane B. Assis
JGJoão P. T. Guimarães
João P. T. Guimarães
ESEmanuella Sousa
Emanuella Sousa
AMAnália C. Milhomem
Anália C. Milhomem
JMJoilson O. Martins
Joilson O. Martins
Alloxan (ALX) and streptozotocin (STZ) are extensively used to induce type 1 diabetes (T1D) in animal models. This study is aimed at evaluating the differences in immune parameters caused by ALX and STZ. T1D was induced either with ALX or with STZ, and the animals were followed for up to 180 days. Both ALX and STZ induced a decrease in the total number of circulating leukocytes and lymphocytes, with an increase in granulocytes when compared to control mice (CT). STZ‐treated mice also exhibited an increase in neutrophils and a reduction in the lymphocyte percentage in the bone marrow. In addition, while the STZ‐treated group showed a decrease in total CD3+, CD4-CD8+, and CD4+CD8+ T lymphocytes in the thymus and CD19+ B lymphocytes in the pancreas and spleen, the ALX group showed an increase in CD4-CD8+ and CD19+ only in the thymus. Basal levels of splenic interleukin‐ (IL‐) 1β and pancreatic IL‐6 in the STZ group were decreased. Both diabetic groups showed atrophy of the thymic medulla and degeneration of pancreatic islets of Langerhans composed of inflammatory infiltration and hyperemia with vasodilation. ALX‐treated mice showed a decrease in reticuloendothelial cells, enhanced lymphocyte/thymocyte cell death, and increased number of Hassall’s corpuscles. Reduced in vitro activation of splenic lymphocytes was found in the STZ‐treated group. Furthermore, mice immunized with ovalbumin (OVA) showed a more intense antigen‐specific paw edema response in the STZ‐treated group, while production of anti‐OVA IgG1 antibodies was similar in both groups. Thereby, important changes in immune cell parameters in vivo and in vitro were found at an early stage of T1D in the STZ‐treated group, whereas alterations in the ALX‐treated group were mostly found in the chronic phase of T1D, including increased mortality rates. These findings suggest that the effects of ALX and STZ influenced, at different times, lymphoid organs and their cell populations.

28 January 2019 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
JGJoão Pedro Tôrres Guimarães
João Pedro Tôrres Guimarães
LFLuciano Ribeiro Filgueiras
Luciano Ribeiro Filgueiras
JMJoilson O. Martins
Joilson O. Martins
SJSonia Jancar
Sonia Jancar
Type 1 diabetes (T1D) is a metabolic disease associated with systemic low-grade inflammation and macrophage reprogramming. There is evidence that this inflammation depends on the increased systemic levels of leukotriene (LT) B4 found in T1D mice, which shifts macrophages towards the proinflammatory (M1) phenotype. Although T1D can be corrected by insulin administration, over time T1D patients can develop insulin resistance that hinders glycemic control. Here, we sought to investigate the role of leukotrienes (LTs) in a metabolically active tissue such as muscle, focusing on the insulin signaling pathway and muscle-associated macrophage profiles. Type 1 diabetes was induced in the 129/SvE mouse strain by streptozotocin (STZ) in mice deficient in the enzyme responsible for LT synthesis (5LO-/-) and the LT-sufficient wild type (WT). The response to insulin was evaluated by the insulin tolerance test (ITT), insulin concentration by ELISA, and Akt phosphorylation by western blotting. The gene expression levels of the insulin receptor and macrophage markers Stat1, MCP-1, Ym1, Arg1, and IL-6 were evaluated by qPCR, and that of IL-10 by ELISA. We observed that after administration of a single dose of insulin to diabetic mice, the reduction in glycemia was more pronounced in 5LO-/- than in WT mice. When muscle homogenates were analyzed, diabetic 5LO-/- mice showed a higher expression of the insulin receptor gene and higher Akt phosphorylation. Moreover, in muscle homogenates from diabetic 5LO-/- mice, the expression of anti-inflammatory macrophage markers Ym1, Arg1, and IL-10 was increased, and the relative expression of the proinflammatory cytokine IL-6 was reduced compared with WT diabetic mice. These results suggest that LTs have an impact on the insulin receptor signaling pathway and modulate the inflammatory profile of muscle-resident macrophages from T1D mice.

22 June 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
KMKalhara Menikdiwela
Kalhara Menikdiwela
JGJoão Pedro Tôrres Guimarães
João Pedro Tôrres Guimarães
SSShane Scoggin
Shane Scoggin
LGLauren S Gollahon
Lauren S Gollahon
Naima Moustaid-MoussaNaima Moustaid-Moussa
Naima Moustaid-Moussa
(1) Consumption of diets that are caloric dense but not nutrient dense have been implicated in metabolic diseases, in part through low-grade metabolic acidosis. Mitigation strategies through dietary intervention to alleviate acidosis have not been previously reported. Our objective is to determine the effects of pH enhancement (with ammonia) in high fat diet-induced obese mice that were fed beef or casein as protein sources compared to low fat diet-fed mice. (2) Methods: B6 male and female mice were randomized (n = 10) into eight diets that differ in protein source, pH enhancement of the protein, and fat content, and fed for 13 weeks: low fat (11% fat) casein (LFC), LF casein pH-enhanced (LFCN), LF lean beef (LFB), LFBN, high fat (46%) casein (HFC), HFCN, HF beef (HFB), and HFBN. Body weights and composition, and glucose tolerance tests were conducted along with terminal serum analyses. Three-way ANOVA was performed. (3) Results: A significant effect of dietary fat (LF vs. HF) was observed across all variables in both sexes (final body weight, fat mass, glucose clearance, and serum leptin). Importantly, pH enhancement significantly reduced adiposity (males only) and final body weights (females only) and significantly improved glucose clearance in both sexes. Lastly, clear sex differences were observed across all variables. (4) Conclusions: Our findings demonstrate metabolic benefits of increasing dietary pH using ammonia, while high fat intake per se (not protein source) is the major contributor to metabolic dysfunctions. Additional research is warranted to determine mechanisms underlying the beneficial effects of pH enhancement, and interactions with dietary fat content and proteins.